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Abstract 
 
Much has been written about airborne particulate matter, and countless meetings, workshops 
and conferences have been held, both nationally and internationally, to address the many 
scientific challenges which they present, especially when one considers their effects on human 
health. Particles are a complex airborne pollutant, because of their many different 
characteristics and the many different ways in which they can be measured and detected. This 
article summarises the current state of knowledge on the effects of particulate matter and 
health, based primarily on epidemiological studies which focused on exposure to particle mass, 
and more recently, on particle number concentration.     
   
Airborne particles – one of the most difficult pollutants to characterise!  
 
The last two decades or so have seen an unprecedented increase in the scientific interest and 
attention paid to airborne particles. A clear turning point for this interest was the publication of 
findings from the Harvard epidemiological studies, which pointed to a better correlation 
between health effects and exposure to fine particles (smaller than 2.5 m) than coarse particles 
(Dockery et al. 1993). These findings led to the introduction of a standard for PM2.5 in the USA 
in 1997. Since then, research on airborne particles and their health effects has accelerated, 
branched in many directions, encountered endless challenges and complexities, and science is 
still far from declaring the final word. 
 
What is so difficult about particles compared to other airborne pollutants? In short, it is the 
multi-factorial nature of airborne particulate matter. While some pollutants, such as carbon 
monoxide, have only one characteristic (i.e. its concentration) averaged over relevant periods of 
exposure, there are many physical, chemical and microbiological characteristics of particulate 
matter which may be considered. One of the fundamental physical properties is size: airborne 
particles range in size over five orders of magnitude, from molecular dimensions to sizes that 
are distinguishable by the naked eye (from about 0.001m to about 100 m; Baron and 
Willeke, 2001). Other physical characteristics of particles include: number concentration, 
number size distribution, mass concentration, mass size distribution, surface area, shape, electrical 
charge and light scattering properties. Usually only some of these properties are measured, and 
almost never all of them, simultaneously. 
An additional complexity is related to the nature of particle formation: primary versus 
secondary particles. A primary is a particle introduced from the source into the air in solid or 
liquid form, while a secondary particle is formed in the air. Particles in the ultrafine (< 0.1 
m) and more generally in the submicrometer size ranges are typically generated by 
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combustion, gas to particle conversion, nucleation or photochemical processes, some of 
which are primary and other which are secondary in nature. In contrast, supermicrometer 
particles are generated by a variety of mechanical processes, and as such, are always primary 
in nature. While understanding the sources and quantification of primary particle emissions is 
relatively more advanced, secondary particles present a far greater challenge, particularly 
since scientific insight into their formation processes is far from complete.  
Particle mass or number? 
 
For several decades, particle mass concentration has been routinely measured by monitoring 
networks around the world, initially as Total Suspended Particles (TSP), then as PM10 and 
more recently as PM2.5 (mass concentration of particles with aerodynamic diameters smaller 
than 10 and 2.5 m, respectively). The growing body of data has served many purposes, 
including, in conjunction with health data, the quantification of exposure-response 
relationships.  
In this field, “the new kids on the block” are ultrafine particles. Because of their small mass, 
they do not substantially contribute to PM2.5 or PM10, and therefore, mass concentration 
measurements provide very little or no information on ultrafine particles. For this reason, they 
are generally measured in terms of number concentration.  
Particle number concentration levels in clean environments, meaning those which are not 
influenced by human activities, are usually in the order of a few hundred particles per cm3. In 
urban environments, almost 90% of the ultrafine particles originate from vehicle combustion 
(Mejia et al. 2008), and urban background particle number concentrations range from a few 
thousand to about twenty thousand particles per cm3 (e.g. Harrison et al. 1999; Thomas and 
Morawska 2002). Background concentrations mean the concentrations measured at monitoring 
stations which are not influenced by a nearby emission source. Near roads and in tunnels, 
vehicular traffic constitutes the most significant urban source of particle number, and particle 
number concentrations can be one or two orders of magnitude higher than the urban 
background, and can reach or exceed levels of 106 particles per cm3 (Morawska 2003, 
Morawska and He 2003, Knibbs et al. 2009). This is in contrast to PM10 and PM2.5 mass 
concentrations, which have been shown to be no more than 25-30% above background levels 
on major roads (Morawska and Salthammer 2003). A practical implication from these findings 
is that, in terms of their number concentration, exposure to airborne particles is significantly 
increased within the first 100 meters from the road, compared to average urban exposure levels, 
and usually decreases to the urban background level at distances greater than 300 m from the 
road. This large variation across different environments has profound significance in relation to 
human exposure assessment and epidemiological studies, and implies that unless exposure 
assessment is conducted where the exposures occur, it is unlikely that epidemiological studies 
would provide meaningful answers based on monitoring in central locations alone.  
Particles mass and health 
Particle mass concentration 
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The relationship between airborne particle mass concentration (PM10 and PM2.5) and health 
outcomes has been extensively investigated (e.g. Pope 2000; Samet et al. 2000; Katsouyanni et 
al. 2001; Dominici 2002; Pope and Dockery 2006). It has been shown that the most significant 
health end points due to the inhalation of particulate matter include: decreased lung function, 
increased respiratory symptoms, increased chronic obstructive pulmonary disease, increased 
cardiovascular and cardiopulmonary disease, and increased mortality. Concentration-response 
relationships based on epidemiological studies conducted mainly in Europe and North America 
were derived by the World Health Organization (WHO) in relation to several health endpoints 
for PM10 and PM2.5 (WHO 2000). As an example, Figure 1 presents the change in the daily 
mortality, hospital admissions, bronchodilator use, symptom exacerbation and peak flow rate as 
a function of PM10 concentration.  
 
Figure 1. Change in health endpoints as a function of PM10 concentration (WHO 2000). 
A more recent literature review on the state of knowledge in relation to particle mass 
concentrations demonstrated that the complexity of the mechanisms by which the inhalation of 
particulate matter can cause health effects are now better understood (Pope and Dockery 2006). 
Figure 2 is a schematic diagram showing how the various mechanisms and impacts are linked 
and how complex the overall picture is. In addition, it was concluded that: 
1. There is no threshold in response,  
2. The response is linear, and  
3. Despite the differences in particle composition, the response is similar over different 
geographic settings.  
This review also showed that, in general, susceptibility depends on the specific end point, as 
well as the level and length of exposure. In particular, those with chronic cardiopulmonary 
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disease/asthma/influenza are affected by short-moderate term exposures, while long term and 
repeated exposure resulted in an increased risk of mortality across a broad based cohort of 
adults and children. 
 
Figure 2. Mechanisms by which the inhalation of particulate matter causes health effects (Pope 
and Dockery 2006). 
Research continues and new studies provide support for the earlier findings or shed more light 
on specific mechanisms or processes. For example epidemiological studies by (Gotschi et al., 
2008) provided further evidence to demonstrate the adverse effect of air pollution on lung 
function, however concluded that the role of specific pollution sources, particularly in terms of 
susceptible populations and relevant exposure periods, still require further investigation; Pope 
et al. (2009) found that a decrease of 10µg m-3 in the concentration of fine particulate matter 
was associated with an estimated increase in mean life expectancy of 0.61 years (p = 0.004), 
while Parker et al. (2009) found that increased allergies and hay fever in children were 
associated with increased PM2.5 (adjusted odds ratio per 10µg m-3 = 1.23, 95% CI = 1.10 - 
1.38). .  
Particle number concentration 
The potential hazards from the inhalation of ultrafine particles by humans are very different to 
those from the inhalation of larger particles, since they are inhaled into much deeper regions of 
the lung and they are not readily removed from the inhaled air in the upper parts of the 
respiratory tract. When deposited in the small containments of the alveoli region in the lung, 
diffusional deposition of particles onto the epithelium becomes an efficient physical 
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mechanism. Alveolar deposition of 0.05 m particles is about 40%, compared to about 10% for 
0.7 m particles (Maynard 2000). In addition, the nanoparticles deposited in this oxygen/blood 
exchange region can penetrate into the blood stream very quickly and efficiently. All of the 
studies conducted thus far demonstrate that the primary determinant of the effect of ultrafine 
particles is their number or surface area, not the weight of the particles (Morawska et al. 2003). 
It should, however, be kept in mind that it is not only the size of ultrafine and nanoparticles 
which differ from larger particles, but there are also substantial differences in their chemical 
properties, and thus the toxicological effects they cause.   
As shown by recent literature reviews (Morawska et al. 2003, Morawska et al. 2007), there 
have only been a relatively small number of epidemiological studies conducted to date. The 
current state of knowledge on the health effects of ultrafine particles can be summarised by 
saying that the array of epidemiological studies conducted so far does suggest that exposure to 
ultrafine particles is associated with respiratory and cardiovascular effects, which holds true 
despite considerable gaps in knowledge and the inconsistencies found between the different 
studies. While both fine and ultrafine particles appear to affect health outcomes, such as 
respiratory and cardiovascular morbidity and mortality, they appear to do so independently of 
each other. Fine particles show more immediate effects, while ultrafine particles show more 
delayed effects on mortality. However, at present, the database is too limited (both in terms of 
number of studies and number of subjects) and geographically restricted, to allow clear 
conclusions to be drawn on the mode of action or generalisation to other settings. The reviews 
showed that one of the main deficiencies of the epidemiological studies conducted to date was 
that they drew on data from central monitoring stations to estimate the level of exposure to 
ultrafine particles. It is now understood that in most cases, this did not accurately represent real 
exposure levels and that the monitoring of ultrafine particles must be done at the same location 
where the exposure occurs. As explained above, exposure to particle number concentrations in 
the proximity to a road, for example, can be more than an order of magnitude higher than away 
from the road. 
Health Guidelines  
Health guidelines in relation to ambient particulate matter, as well as other environmental 
pollutants, are published by the World Health Organization (WHO) and adopted based on 
expert panel agreements, following the consideration of evidence from medical and public 
health studies. As stressed in the latest edition of the guidelines, they are written “for 
worldwide use, intended to support actions aiming for air quality at the optimal achievable 
level of public health protection in different contexts” (WHO, 2005). 
The values chosen for the WHO air quality guidelines (WHO, 2005), which apply to both 
outdoor and indoor air are: 
PM2.5: 10 μg/m
3 
annual mean, 25 μg/m3 24-hour mean  
PM10: 20 μg/m
3 
annual mean, 50 μg/m3 24-hour mean  
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The composition of particles is likely to vary substantially between cities around the world, 
depending on the specific local sources present in the area. However, since similar effect 
estimates have been reported across cities in developed and developing countries, despite 
likely differences in fractional contribution from different sources, and thus particle 
composition, it was concluded that it is reasonable to assume generally similar effects of 
particle mass from these different sources.   
The rationale for the choice of the annual average guideline value of 10 μg/ m3 for PM2.5 was 
that it represents the lower end of the range over which significant effects on survival have 
been observed in the American Cancer Society Study (ACS) (Pope et al., 2002). Further 
discussion on these findings can be found in the document WHO air quality guidelines 
(WHO 2005), which also conclude that, although adverse effects on health cannot be entirely 
ruled out even below that level, it is a level achievable in the urban areas of developed 
countries, and therefore, adhering to it is expected to effectively reduce the health risks. 
However, experts emphasized the need to reduce exposure to non-threshold pollutants, such 
as particulate matter, even where current concentrations are close to or below the proposed 
guidelines.  
In relation particle number (ultrafine particles), it was stated in the same document that: “While 
there is considerable toxicological evidence of potential detrimental effects of ultrafine 
particles on human health, the existing body of epidemiological evidence is insufficient to 
conclude on exposure/response relationship to ultrafine particles. Therefore no 
recommendations can be provided as to guideline concentrations of these particles at this 
point." (WHO, 2005). 
It should be noted that the lower range of concentrations at which effects have been 
demonstrated is not significantly greater than the background PM2.5 concentration (estimated 
at 3-5 μg/m3, but it should be acknowledged that, in some locations and under some 
circumstances, concentrations in natural environments may be well below or above those 
cited). If future epidemiological studies report responses at lower PM2.5 and PM10 
concentration levels, it is likely that the guideline values will be lowered even further. While 
lack of an exposure-response relationship makes it impossible to propose health guidelines 
for ultrafine particles, it is important to point out that, as discussed above, the current levels 
in environments affected by vehicle emissions are up to two orders of magnitude higher than 
in natural environments. Thus, if there is also no threshold response level in relation to 
exposure to ultrafine particles (or if it is very low), future health guidelines may recommend 
reducing these particles in urban environments by more than one order of magnitude. At 
present there is a long way to go to order to achieve this.  
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